NICE Launches a competition for developers of healthcare technologies
NICE Scientific Advice has launched a competition for small or medium sized companies, charities and academic research groups, who are developing transformative products that have the potential to change patients’ lives and/or save the NHS money. The NICE AdviSeME Prize is open to products (pharmaceuticals, devices, diagnostic test/tools, cell/gene therapies, healthcare apps) in the early clinical stages
Topical administration of Esculetin as a potential therapy for experimental dry eye syndrome – (Eye Journal AOP)
Topical administration of Esculetin as a potential therapy for experimental dry eye syndrome Eye advance online publication, June 23 2017. doi:10.1038/eye.2017.117 Authors: D Jiang, X Liu & J Hu
Deep sclerectomy for uveitic glaucoma: long-term outcomes – (Eye Journal AOP)
Deep sclerectomy for uveitic glaucoma: long-term outcomes Eye advance online publication, June 23 2017. doi:10.1038/eye.2017.80 Authors: K Mercieca, L Steeples & N Anand
Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration – (Eye Journal AOP)
Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration Eye advance online publication, June 23 2017. doi:10.1038/eye.2017.86 Authors: J S Talks, P James, S Sivaprasad, R L Johnston, M McKibbin & UK Aflibercept Users Group
Benchmarking cataract surgery outcomes in an ethnically diverse and diabetic population: final post-operative visual acuity and rates of post-operative cystoid macular oedema – (Eye Journal AOP)
Benchmarking cataract surgery outcomes in an ethnically diverse and diabetic population: final post-operative visual acuity and rates of post-operative cystoid macular oedema Eye advance online publication, June 23 2017. doi:10.1038/eye.2017.96 Authors: K Oyewole, F Tsogkas, M Westcott & S Patra